Advertisements



Emergent BioSolutions prepares for initial shipments of AV7909 to SNS

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMay 15th, 2019

Emergent BioSolutions, Vertex partner to develop oral COVID-19 vaccine

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 18th, 2020

Emergent BioSolutions CEO Talks Coronavirus Vaccine Development

Global life sciences company Emergent Biosolutions Inc (NYSE: EBS) CEO Bob Kramer said Thursday that his company's partnership with read more.....»»

Category: blogSource: benzingaMar 12th, 2020

Novavax’s coronavirus vaccine program is getting some help from Emergent BioSolutions

N.....»»

Category: topSource: bizjournalsMar 10th, 2020

Emergent BioSolutions enters agreement with Novavax

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 10th, 2020

Emergent BioSolutions Moves Up In Market Cap Rank, Passing Cimarex Energy

Market News Video.....»»

Category: topSource: redinewsMar 5th, 2020

Emergent BioSolutions selects Axiom Fusion eClinical suite

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 4th, 2020

GenMark announces initial shipments of ePlex test kits

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallMar 2nd, 2020

Emergent BioSolutions price target raised to $75 from $66 at Wells Fargo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 25th, 2020

Emergent BioSolutions sees FY20 revenue $1.175B-$1.275B, consensus $1.23B

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 20th, 2020

Emergent BioSolutions sees Q1 revenue $190M-$215M, consensus $262.06M

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 20th, 2020

Emergent BioSolutions reports Q4 EPS $1.57, consensus $1.73

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 20th, 2020

Emergent BioSolutions enters into Narcan settlement agreement with Perrigo

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallFeb 19th, 2020

Emergent BioSolutions receives positive CHMP opinion for Vaxchora

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 31st, 2020

Emergent BioSolutions: EMA approves plan for CHIKV VLP vaccine candidate

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 13th, 2020

Emergent BioSolutions sees FY19 revenue $1.1B, consensus $1.11B

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallJan 13th, 2020

Emergent BioSolutions presents immunogenicity results from Phase 2 study

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 22nd, 2019

Cantor reiterates Overweight on Emergent BioSolutions with $75 price target

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 22nd, 2019

Emergent BioSolutions announces five-year growth strategy

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 21st, 2019

Emergent BioSolutions to host analyst & investor day

See the rest of the story here. Theflyonthewall.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fl.....»»

Category: blogSource: theflyonthewallNov 19th, 2019

Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q3 2019 Results - Earnings Call Transcript

Emergent BioSolutions Inc. (EBS) CEO Bob Kramer on Q3 2019 Results - Earnings Call Transcript.....»»

Category: topSource: seekingalphaNov 7th, 2019